Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impaired Differentiation of Chronic Obstructive Pulmonary Disease Bronchial Epithelial Cells Grown on Bronchial Scaffolds. | Am J Respir Cell Mol Biol | 2021 | 33882260 | PubTator, text mining | PubMed |
| Roles of miRNAs in Colorectal Cancer: Therapeutic Implications and Clinical Opportunities. | Adv Pharm Bull | 2021 | 33880345 | PubTator, text mining | PubMed |
| RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease. | Cancer Discov | 2021 | 33879449 | PubTator, text mining | PubMed |
| Comprehensive analysis of IgA nephropathy expression profiles: identification of potential biomarkers and therapeutic agents. | BMC Nephrol | 2021 | 33874912 | PubTator, text mining | PubMed |
| Quantitative proteome comparison of human hearts with those of model organisms. | PLoS Biol | 2021 | 33872299 | PubTator, text mining | PubMed |
| Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis. | Front Oncol | 2021 | 33869048 | PubTator, text mining | PubMed |
| CUL4B Promotes Temozolomide Resistance in Gliomas by Epigenetically Repressing CDNK1A Transcription. | Front Oncol | 2021 | 33869025 | PubTator, text mining | PubMed |
| An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. | Nat Commun | 2021 | 33863885 | PubTator, text mining | PubMed |
| MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells. | Cancer Cell Int | 2021 | 33858435 | PubTator, text mining | PubMed |
| Up-Regulating ERIC by CRISPR-dCas9-VPR Inhibits Cell Proliferation and Invasion and Promotes Apoptosis in Human Bladder Cancer. | Front Mol Biosci | 2021 | 33855049 | PubTator, text mining | PubMed |
| MiR-573 suppresses cell proliferation, migration and invasion via regulation of E2F3 in pancreatic cancer. | J Cancer | 2021 | 33854603 | PubTator, text mining | PubMed |
| Tip of the Iceberg: Roles of CircRNAs in Cancer Glycolysis. | Onco Targets Ther | 2021 | 33854335 | PubTator, text mining | PubMed |
| CRL4AMBRA1 is a master regulator of D-type cyclins. | Nature | 2021 | 33854235 | PubTator, text mining | PubMed |
| CytoTalk: De novo construction of signal transduction networks using single-cell transcriptomic data. | Sci Adv | 2021 | 33853780 | PubTator, text mining | PubMed |
| Circular RNA circZNF292 regulates H2 O2 -induced injury in human lens epithelial HLE-B3 cells depending on the regulation of the miR-222-3p/E2F3 axis. | Cell Biol Int | 2021 | 33851769 | PubTator, text mining | PubMed |
| Identification and analysis of spinal cord injury subtypes using weighted gene co-expression network analysis. | Ann Transl Med | 2021 | 33850863 | PubTator, text mining | PubMed |
| miR-20a-5p inhibits endometrial cancer progression by targeting janus kinase 1. | Oncol Lett | 2021 | 33850568 | PubTator, text mining | PubMed |
| How metformin affects various malignancies by means of microRNAs: a brief review. | Cancer Cell Int | 2021 | 33849540 | PubTator, text mining | PubMed |
| Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma. | Oncogene | 2021 | 33846574 | PubTator, text mining | PubMed |
| Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression. | Exp Mol Pathol | 2021 | 33844975 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=57